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Abstract
Background: NF-κB binds to the κB motif to regulate transcription of genes involved in growth,
immunity and inflammation, and plays a pivotal role in the production of pro-inflammatory
cytokines after nerve injuries. The zinc finger protein ZAS3 also binds to the κB or similar motif.
In addition to competition for common DNA sites, in vitro experiments have shown that ZAS3 can
inhibit NF-κB via the association with TRAF2 to inhibit the nuclear translocation of NF-κB.
However, the physiological significance of the ZAS3-mediated inhibition of NF-κB has not been
demonstrated. The purpose of this study is to characterize ZAS3 proteins in nervous tissues and
to use spinal nerve ligation, a neuropathic pain model, to demonstrate a functional relationship
between ZAS3 and NF-κB.
Results: Immunohistochemical experiments show that ZAS3 is expressed in specific regions of the
central and peripheral nervous system. Abundant ZAS3 expression is found in the trigeminal
ganglion, hippocampal formation, dorsal root ganglia, and motoneurons. Low levels of ZAS3
expressions are also found in the cerebral cortex and in the grey matter of the spinal cord. In those
nervous tissues, ZAS3 is expressed mainly in the cell bodies of neurons and astrocytes. Together
with results of Western blot analyses, the data suggest that ZAS3 protein isoforms with differential
cellular distribution are produced in a cell-specific manner. Further, neuropathic pain confirmed by
persistent mechanical allodynia was manifested in rats seven days after L5 and L6 lumbar spinal
nerve ligation. Changes in gene expression, including a decrease in ZAS3 and an increase in the p65
subunit of NF-κB were observed in dorsal root ganglion ipsilateral to the ligation when compared
to the contralateral side.
Conclusion:  ZAS3 is expressed in nervous tissues involved in cognitive function and pain
modulation. The down-regulation of ZAS3 after peripheral nerve injury may lead to activation of
NF-κB, allowing Wallerian regeneration and induction of NF-κB-dependent gene expression,
including pro-inflammatory cytokines. We propose that reciprocal changes in the expression of
ZAS3 and NF-κB might generate neuropathic pain after peripheral nerve injury.
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Background
Peripheral nerve injury typically leads to multiple physio-
logical alterations of the peripheral and central nervous
system that includes changes in neuronal phenotype,
increased excitability of spinal cord neurons, i.e., central
sensitization, glial activation and disinhibition [1]. Col-
lectively, these phenomena lead to the development and
maintenance of neuropathic pain, through a complex web
of signals and molecules that include inflammatory medi-
ators at the site of injury, neurotransmitters, and chemok-
ines at spinal cord synapses. Recent microarray
experiments have further identified many genes that may
contribute to neuropathic pain [2,3] Therefore, identify-
ing the early events, namely the transcription factors, that
trigger neuropathic pain may help to develop therapies to
prevent or minimize the symptoms of this debilitating
disease. Nerve injury induces production of pro-inflam-
matory cytokines, such as tumor necrosis factor alpha
(TNFα), interleukin (IL)-1beta and IL-6, has been shown
to play a key role in the propagation of neuropathic pain
in animal models and human disease [4,5]. NF-κB is a key
transcription factor that regulates the expression of those
cytokine genes via the κB motif present in the promoters
or enhancers [6-8] Consequently, NF-κB emerges as a
potential drug target in the treatment of pathological pain
[9-11]
The κB motif is a gene regulatory element controlling the
expression of many genes involved in growth, immunity
and inflammation. The regulation of κB-dependent tran-
scription by the Rel family of NF-κB is well established
[12,13] Recent studies, however, show that a family of
large zinc finger proteins, called ZAS, also shares target
genes with NF-κB [14]. Whereas NF-κB mostly induces
transcription, ZAS proteins can positively [15-17] or neg-
atively [18-20] regulate transcription. Additionally, a rep-
resentative ZAS family member, ZAS3 (also known as Rc/
KRC/HIVEP3), associates with an adaptor molecule in the
TNFα signal transduction pathway, TNF receptor-associ-
ated factor 2 (TRAF2), to inhibit the nuclear translocation
and transcriptional activity of NF-κB [20,21] Therefore,
the interplay between ZAS3 and NF-κB may control
important physiological processes, such as cell growth,
apoptosis and cytokine expression.
RNA studies have shown that ZAS3 transcripts are
expressed specifically in the lymphoid and nervous sys-
tems [22-24] Characterization of ZAS deficient mice sug-
gests that ZAS2 and ZAS3 are involved in lymphoid
development. There was a marked deficit in
CD4(+)CD8(+) thymocytes in 6-month-old ZAS3(-/-
);RAG2(-/-) chimeric mice, suggesting that ZAS3 is
involved in T lymphocyte survival [25]. In addition, NF-
κB is constitutively activated in ZAS3-deficient B cells,
supporting the notion that ZAS3 associates with TRAF2 to
inhibit NF-κB activation [20]. Similarly, in ZAS2-deficient
mice, dramatic enhancement in the differentiation into T
helper type 2 cells, constitutive activation of NF-κB, and
enhanced GATA3 induction were observed [26]. There-
fore, the ZAS proteins are able to inhibit NF-κB-driven
transcription by competing with NF-κB for binding to
DNA sequences similar to the κB motif and by inhibiting
NF-κB activation [26]. However, the role of ZAS in the
nervous system has not been studied. In the present work,
ZAS3 proteins in nervous tissues have been characterized
using two independent ZAS3 antisera. Abundant ZAS3
expression is found in neuronal cell bodies of the hippoc-
ampus formation, trigeminal ganglion, dorsal root gan-
glia (DRG), and motoneurons, and in astrocytes of the
brain and spinal cord. Additionally, the down-regulation
of ZAS3 and up-regulation of NF-κB in DRG after periph-
eral nerve injury suggests these κB-transcriptional proteins
may be involved in neuronal regeneration and neuro-
pathic pain.
Results
The distribution of ZAS3 proteins in the rat nervous tis-
sues was first determined by immunohistochemical pro-
cedures using ZAS3-specific antisera, AbN and AbC. Those
antisera were raised against fusion proteins containing
different vector encoded sequences and distinct regions of
ZAS3 (Figure 1A). Each antiserum only interacted with the
cognate antigens [17]. Consecutive rat coronal brain sec-
tions corresponded to the plane of bregma from -1 mm to
-10 mm according to a stereotaxic atlas [27], longitudinal
sections of isolated trigeminal ganglion, L3 to L6 DRG,
and cross-sections of lumbar spinal cord were examined.
ZAS3 expression in trigeminal ganglion
ZAS3-immunoreactivity (IR) was readily observed in the
trigeminal ganglion, in agreement with abundant ZAS3
transcripts present in this tissue [24]. The signal intensity
was strong from neuronal cell bodies and weak from
nerve fibers (Figure 1B and 1C). Examination of individ-
ual ganglion nerve cell bodies under high power magnifi-
cation revealed that signals derived from AbN were
distributed uniformly between cytoplasm and nucleus
(Figure 1B), whereas AbC yielded more intense signals
from the nucleus (Figure 1C).
ZAS3 in dorsal root ganglia
DRG was another nervous tissue where ZAS3-IR was read-
ily observed (Figure 1D and 1E). Notably, AbN yielded
intense signals mainly from large neurons, whereas AbC
yielded similar signals from large, medium and small neu-
rons. Similar to the immunostaining of the trigeminal
ganglion, AbC yielded more prominent signals from the
nuclei than from cytoplasm of DRG neurons, whereas sig-
nals from AbN were mostly cytoplasmic.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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ZAS3 in neurons and astrocytes of hippocampal formation 
and cerebral cortex
Inspection of coronal sections through the septal half of
the hippocampus showed abundant ZAS3-IR at the hip-
pocampal formation (Figure 2). The expression of ZAS3
transcripts in the hippocampus of mouse embryos had
not been seen in previous studies because para-sagittal
sections were used for in situ hybridization [22,24] Neuro-
nal cell bodies, including the pyramidal cells of the hip-
pocampus proper Ammon's horn fields CA1, CA2 and
CA3, and granule cells of the dentate gyrus, appeared as
dark granules at low magnifications when stained with
cresyl violet (Figure 2A). Cresyl violet reacted with the
Nissl substance that was abundant in neuronal cell bod-
ies. The pattern of ZAS3-IR in the hippocampal formation
resembled that of cresyl violet in that both stained neuro-
nal cell bodies (Figure 2B).
The granule layer of the dentate gyrus consists mostly of
neurons, whereas the pyramidal cell layers of the hippoc-
ampus have a larger glial population relative to neurons.
In these hippocampus regions, AbC labeled only neurons
(Figure 2C). On the other hand, AbN yielded modest
labeling of neurons and more intense labeling of adjacent
star-like cells that had elaborate processes (Figure 2D).
Similar differential labeling pattern of both antibodies
was observed in the cerebral cortex. Double labeling of the
cortex with an antibody for the astroglial marker GFAP
[28] confirmed that those AbN-positive cells were astro-
cytes (Figure 3A). Additionally, in neurons of hippocam-
pus formation and cerebral cortex, AbN yielded stronger
signals from the cytoplasm than from the nucleus (Figure
3B). On the other hand, the AbC signal was observed in
nuclei but not in cytoplasm of neurons in the hippocam-
pus (Figure 3C). Further, double labeling experiments
with AbC and GFAP antibodies revealed that AbC only
yielded signals from neurons but not from GFAP-positive
cells. The ability of AbN but not AbC to react with astro-
cytes suggests that astrocytes may produce a ZAS3 isoform
that does not contain the ZASC domain.
Expression of ZAS3 in neuronal cell bodies and astrocytes at  the hippocampal formation Figure 2
Expression of ZAS3 in neuronal cell bodies and astrocytes at 
the hippocampal formation. (A) Rat coronal brain section 
(Bregma -3.80) stained with cresyl violet; (B) immunostaining 
of a similar brain sections with AbC; (C) CA2 region stained 
with AbC; and (D) CA3 region stained with AbN. Star-like 
AbN-positive cells are highlighted with arrows. pcl, pyramidal 
cell layer; sl, stratum lucidum; PL, GL and ML, polymorphic, 
granule and molecular cell layer, respectively, of the dentate 
gyrus. Scale bars represent 2 mm (A and B); 0.2 mm (C); 0.1 
mm (D).
Primary structure of ZAS3 and expression of ZAS3 in the  trigeminal ganglion and dorsal root ganglia Figure 1
Primary structure of ZAS3 and expression of ZAS3 in the 
trigeminal ganglion and dorsal root ganglia. (A) Schema 
showing the domain structure of the ZAS3 protein and 
fusion proteins used to raise polyclonal antisera, AbN and 
AbC. Black boxes, zinc finger(s); grey box, middle conserved 
region; ZAS, zinc finger, acidic- and serine/threonine-rich 
regions; S, S protein; and mbp, maltose binding protein. (B) 
and (C) Immunohistochemical staining of sections of naïve rat 
trigeminal ganglion using antisera AbN and AbC, respectively. 
Inserts are higher magnifications showing uniform cellular 
staining of AbN and prominent nuclear staining with AbC. 
Bars represent 200 µM. (D) and (E) Longitudinal sections of 
DRG immunostained with AbN and AbC, respectively. 
Arrows highlight differential nuclear staining of AbN and 
AbC. Bars represent 100 µM.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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ZAS3 in motoneurons
The overall expression of ZAS3 was low in the lumbar spi-
nal cord, where a more intense signal was observed in the
grey matter than the white matter (Figure 4). Notably,
abundant ZAS3-IR was observed in motoneurons in the
ventral horn of the spinal cord (Figure 5). Double staining
with ZAS3 antibodies and DAPI showed some cell nuclei
that were devoid of ZAS3 (compared circled cells in Figure
5A and 5B for AbN and Figure 5G,H and 5I for AbC),
showing that these antisera stained cells specifically.
Again, AbC stained only the nuclei, whereas AbN stained
both the nuclei and cytoplasm of motoneuorns. In addi-
tion, AbN also stained astrocytes, which were also posi-
tively labeling by antibodies against GFAP (such
astrocytes were highlighted with white arrows in Figure
5A, 5C and 5E). As in the brain tissues examined, AbC
stained only neurons in the spinal cord, whereas AbN
stained both neurons and astrocytes.
The distribution of ZAS3 in various nervous tissues exam-
ined is summarized in Table 2. The similar tissue distribu-
tion of immunoreactivity derived from AbN and AbC,
antibodies that were raised against distinct regions of
ZAS3, suggests that these antibodies are specific for the
endogenous proteins. In addition, AbC-IR is generally
more abundant in the nucleus than cytoplasm, whereas
Expression of ZAS3 in astrocytes and neurons in the brain cortex Figure 3
Expression of ZAS3 in astrocytes and neurons in the brain cortex. (A) Images of sections of brain cortex stained with AbN 
(left) and GFAP antibodies (middle). The images were superimposed in the right. Most AbN-IR cells were also stained by GFAP 
antibodies. Whereas AbN stained the cell bodies and the cylindrical processes, GFAP also stained the more elongated branch-
ing processes. An example of a cell stained with both AbN and GFAP antibodies is shown in a circle. (B) and (C) are high mag-
nification of neurons stained with AbN, and AbC, respectively and DAPI. While AbC stained the nucleus, AbN yielded intense 
cytoplasmic staining.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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the reverse is true for AbN. Furthermore, both ZAS3 anti-
bodies reacted with neurons, whereas only AbN also
reacted with GFAP-positive cells, which are astrocytes.
Production of ZAS3 protein isoforms
Next, immunoblot analyses were performed to clarify the
origin of the observed differences in the intensity of ZAS3-
IRs between cytoplasm and nucleus. In total lysates of the
brain, AbC reacted with two protein species of 190 kDa
and 160 kDa in size (Figure 6A, lane 1). The smaller 160
kDa ZAS3 was present in both cytoplasmic and nuclear
extracts, whereas the 190 kDa ZAS3 was observed only in
the nuclear extracts (Figure 6A, lanes 2 and 3). AbC also
reacted with two species in DRG, but with slightly
retarded gel mobilities (Figure 6A, lane 4). The slower
migrating species was found in the nuclear extracts,
whereas the faster migrating species was present in the
cytoplasmic extracts (Figure 6A, lanes 5 and 6). On the
other hand, AbN reacted with a single 190 kDa species in
the brain, but with two species of 200 kDa and 70 kDa in
DRG (Figure 6C). In DRG, The 200 kDa species was
observed in the nuclear extracts, whereas the 70 kDa pro-
tein was found in the cytoplasmic extracts. In general, the
relative signal intensity observed from cytoplasmic
extracts and nuclear extracts in immunoblotting was con-
sistent with what we had observed in the immunohisto-
chemical studies. The various species reacting with the
ZAS3 antibodies suggest that ZAS3 isoforms were pro-
duced in a tissue-specific manner. As controls, equivalent
loadings were visualized by protein staining before trans-
ferring proteins from gels onto nitrocellulose membranes,
and p65-IRs were detected mainly from total protein
lysates and cytoplasmic extracts, and minimally from
nuclear extracts (Figure 6B). In most cell types, p65 asso-
ciated with IκB and was therefore sequestered in the cyto-
plasm. The difference in gel mobility, immunogenicity,
and cytoplasmic or nuclear distribution of ZAS3 isoforms
suggest that the regulation of ZAS3 expression is complex
and is different between brain and DRG.
SpNL rats exhibit allodynia
A widely used peripheral neuropathy model, the L5/L6
spinal nerve ligation model (SpNL) [29] was used to
examine whether ZAS3 may have a role in regenerative
responses after peripheral nerve injury. Persistent allody-
nia, pain resulting from a non-painful stimulus, such as a
light touch, is also a common characteristic of neuropa-
thy. The behavioral changes of SpNL rats due to neuro-
Table 1: Gene-specific primer sets for RT-PCR
Gene forward primer/reversed primer PCR product size (bp)
NGF 481 TCATCCACCCACCCAGTC 498
834 TCTTGCAGCCTTCCTGCT 817
354
β-actin 382 CACCCTGTGCTGCTCAC 398
598 GAGGGAGCGCGTAACCCT 581
217
ZAS1 6832 ACTCCCATCTCCCCAGAAGT 6851
7081 ACGGTTGCAAGGTTATTTGC 7062
250
ZAS2 7211 ATGGGGCAGTATCTGCAAAG 7229
7395 TGAGAATGGAGGGGAAGATG 7376
185








Expression of ZAS3 in the spinal cord Figure 4
Expression of ZAS3 in the spinal cord. Cross section of rat L3 spinal cord stained with (A) pre-immune sera, (B) AbC, and (C) 
AbN. The expression of ZAS3 was higher in the grey matter than white matter.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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pathic pain after spinal nerve injury were confirmed by
exhibition of mechanical allodynia in the left rear paw, i.e.
the side ipsilateral to surgery, at day 6 post-operative.
SpNL pre-surgery = 17.03 ± 2.89 g, post-surgery = 5.48 ±
3.32 g; p = 0.032 two-tailed Mann-Whitney non-paramet-
ric (n = 5). SHAM rats did not exhibit allodynia (pre-sur-
gery = 23.11 ± 0.88 g; 6 days post-surgery 21.79 ± 2.2 g; n
= 3); SpNL rats had maximum test values on the contral-
ateral side 6 days post-surgery.
In Silico cloning of rat ZAS3
The relative amount of ZAS3 transcripts from ipsilateral
and contralateral L5 and L6 DRG was compared by RT-
PCR. Because rat ZAS3 had not been cloned, we first com-
piled an 8759 bp rat ZAS3 cDNA by in silico cloning pro-
cedure as described in Experimental procedures. The open
reading frame of rat ZAS3 encodes a protein of 2342
amino acids, which is 92% identical to the mouse coun-
terpart (Figure 7A). The cDNA was derived from 8 exons
Expression of ZAS3 in motoneurons of lumbar spinal cord Figure 5
Expression of ZAS3 in motoneurons of lumbar spinal cord. Triple fluorescent ZAS3, GFAP, and DAPI staining of lumber spinal 
cord sections. Many cell nuclei were devoid of ZAS3 (circled), suggesting that the antisera, AbC and AbN, were specific. While 
AbC stained the nuclei of motoneurons, AbN stained both the nuclei and cytoplasm of motoneuorns and astrocytes. When 
the images of AbN and GFAP are superimposed, cells that expressed both proteins are yellow (highlighted with a white arrow 
in A, C, and E). When the images of AbC and DAPI are superimposed, nuclei expressing ZAS3 appear purple (highlighted with 
a yellow arrow), whereas nuclei that did not express ZAS3 are blue (circled).BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
Page 7 of 13
(page number not for citation purposes)
and covering a genomic region of 47 kb. Because the 5'
end of the rat ZAS3 gene has not been characterized, the
exon numbering of the mouse gene was used (Figure 7B).
The 3' organization of the rat ZAS3 gene was largely simi-
lar to the mouse gene, and the exon and intron bounda-
ries were also conserved. GenBank databases contained a
shorter rat ZAS3 cDNA of 7440 bp (XM_233464), which
was predicted by automated computational analysis of
the gene sequence. Although XM_233464 was shorter, it
encoded 2479 amino acids because it contained an inser-
tion of 390 bp between exon 12 and exon 13. A compari-
son with the genomic sequence showed that those extra
sequences were derived from two putative protein-coding
exons (indicated with vertical arrows in Figure 7B). That
390 bp sequence, however, were not conserved in humans
or mice, casting doubts onto its authenticity of being
included in mature transcripts.
Downregulation of ZAS transcripts in SpNL rats
Seven days post-surgery, L5 and L6 DRGs were analyzed
for ZAS3 mRNA expression by semi-quantitative RT-PCR.
Two primer sets were used to amplify distinct regions. The
5' region covers a 459 bp sequence, which corresponds to
intron 10 of the mouse ZAS3 gene. Intron 10 is unusual in
that when retained in transcripts it encodes the ZASN
domain [30]. As in the mouse, the corresponding
sequence in the rat starts with GC and ends with AG,
which are splicing dinucleotides, allowing that 459 nucle-
otide sequence to serve as a potential intron. The 3' region
contains exon 13, which is a 176 nucleotide sequence that
encodes the carboxyl zinc finger pair of the ZASC domain.
Those regions were chosen for amplification because they
have been shown to be involved in alternative splicing in
mouse (27). The alternative splicing of intron 10 will lead
to the production of ZAS3 protein isoforms that lack the
ZASN domain, whereas alternative splicing of exon 13
will lead to premature translation termination and pro-
duction of carboxyl-truncated proteins that lack the ZASC
domain [30].
Seven days after SpNL surgery, ZAS3 mRNA levels were
less in ipsilateral DRG than in contralateral DRG, suggest-
ing that ZAS3 is downregulated in SpNL (Figure 8A). The
formation of two PCR products of 601 bp and 422 bp
using the 3' primer set showed that exon 13 of rat (Figure
8A, lanes 3 and 10), as in humans [31] and mice [30], was
also involved in alternative splicing. Because the extra
sequence in XM_233464 described in the above lies
between exon 12 and exon 13 (Figure 7B), the lack of
larger PCR products in this experiment supports our
notion that the 390 bp sequence do not correspond to
exons. On the other hand, alternative splicing of the ZASN
region was not evident because only a PCR product of 588
bp, but no smaller products, was produced using the 5'
primer set (Figure 8A, lanes 2 and 9). To determine
whether downregulation in SpNL was specific for ZAS3 in
the ZAS gene family, RT-PCR was also performed with
ZAS1 and ZAS2 specific primer sets. ZAS1 and ZAS2 were
also downregulated in DRG after SpNL. Nerve growth fac-
tor (NGF), whose expression was upregulated in SpNL
[32], was used as a control for SpNL (Figure 8A, compare
lane 6 and lane 13). Data from four independent experi-
ments were summarized and presented in the lower panel
of Figure 8A.
Downregulation of ZAS3 proteins and upregulation of NF-
κB in SpNL
Immunoblot analysis of total protein lysates revealed two
species of 200 kDa and 190 KDa that reacted with AbC in
contralateral DRG (Figure 8Ba, lane 2). In ipsilateral DRG,
only the faster migrating species was observed (Figure
8Ba, lane 1). Similarly, the 70 kDa species, which reacted
with AbN, was significantly diminished in ipsilateral DRG
(Figure 8Bb, compare lane 1 and 2). Consistent with a
decrease of ZAS3 and the inhibitory role of ZAS3 on NF-
κB, the amount of p65 in the ipsilateral DRG was higher
than that in the contralateral DRG (Figure 8Bc). Further-
more, the ratio of nuclear to cytoplasmic p65 in DRG of
neuropathic rat was higher than that of SHAM rat (Figure
8C). The protein filter was also hybridized with antibod-
ies against histone H1 as a control for nuclear extracts.
Therefore, in SpNL ZAS3 was downregulated while NF-κB
was upregulated.
Discussion
This study localizes ZAS3 protein expression in neuronal
cell bodies of the hippocampus proper and dentate gyrus
(Figure 2), which contain groups of nerves that play a cru-
cial role in the mechanisms of learning, emotion and
memory. Abundant ZAS3 protein expression was also
found in the trigeminal ganglion and DRG (Fig. 1). The
Table 2: Tissue and cellular distribution of ZAS3-IRs





Neurons + (cyto > nuc) ++ (nuc)
astrocytes ++ -
Trigeminal ganglion
Neurons ++ (cyto ~ nuc) ++ (nuc > cyto)
Cerebral cortex
Neurons + (cyto > nuc) ++ (nuc)
Astrocytes ++ -
DRG
Neurons ++ (cyto > nuc) ++ (nuc > cyto)
Lumbar spinal cord
Motoneurons ++ (cyto ~ nuc) ++ (nuc)
astrocytes ++ -
background signals (-); relative signal intensity is reflected by the 
number of (+); cyto, cytoplasm; and nuc, nucleus.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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trigeminal ganglion and DRG are equivalent structures,
containing mostly neural crest-derived sensory neurons,
which convey pain information from peripheral to central
nervous system. DRG contain the spinal nerve's cell bod-
ies and receive signals from the site of peripheral nerve
injury to affect transcription and alter expression of neu-
rotransmitters, receptors, and ion channels involved in
modulating nociception. Additionally, ZAS3 expression is
found in astrocytes in brain and spinal cord. Astrocytes are
the major cell type in the brain and spinal cord whose
function was previously thought to be limited to main-
taining homeostasis for neuronal signaling [33]. Recently,
we have shown increased astrocyte reactivity in the spinal
cord after SpNL [34], and astrocyte activation is regarded
as a driving force for creating and maintaining pathologi-
cal pain states [35].
The expression pattern of ZAS3 in the nervous system
prompted us to investigate whether ZAS3 plays a role in
neuropathic pain, a pathological condition in which pain
is evoked at much lower stimulus thresholds and often
with greater severity. ZAS3 inhibits NF-κB, which regu-
lates the transcription of proinflammatory cytokines,
including IL-1, IL-6, and TNFα. Inflammation can lower
nociceptor thresholds and increase neuronal excitability.
We show for the first time that the expression of ZAS3 and
its related genes, ZAS1 and ZAS2, is decreased in the ipsi-
lateral versus contralateral L6 DRG seven days after SpNL
(Figure 8). Rat DRG neurons survive and regenerate
injured axons after nerve injury [36]. Because ZAS3 sup-
presses growth [25,37]. and NF-κB acts as a survival factor
and promotes growth, the downregulation of ZAS3 and
upregulation of NF-κB might be adaptations for sensory
neuron mediated axonal regeneration after peripheral
nerve injury.
It has been shown that injection of a NF-κB decoy, inhib-
itor for IkappaB kinase (IKK), or a TNFα antagonist to or
near nerve lesions attenuated SpNL-induced mechanical
allodynia or the upregulation of NF-κB-dependent genes
[9,38]. In agreement with previous findings which
showed that ZAS3 inhibits NF-κB [20], the downregula-
tion of ZAS3 is in parallel with upregulation of NF-κB in
SpNL. Therefore, the data suggest that a neuronal inflam-
matory cascade in DRG that involves ZAS3 and NF-κB
may be important for the pathogenesis of neuropathic
pain. The expression of ZAS3 in neurons of DRG and
trigeminal ganglia, and in astrocytes, together with its
The rat ZAS3 gene and gene products Figure 7
The rat ZAS3 gene and gene products. (A) A diagonal blot of the rat ZAS3 cDNA against mouse ZAS3 cDNA. (B) Schema of 
the rat ZAS3 gene (top panel), the complete protein product (middle panel), and a product generated by alternative splicing of 
exon 13 (bottom panel). White boxes represent exons; vertical arrows indicate two additional exons corresponded to a 
cDNA sequence present in GenBank databases (XM_233464); asterisk highlights exon 13 that is involved in alternative splicing; 
horizontal arrows mark the positions of primers used in RT-PCR; and black boxes represent zinc finger pairs. The 5' end of the 
rat ZAS3 gene has not been elucidated. Therefore, exon numberings, referring to the mouse gene, are shown on top of exons.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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reduction in DRG after SpNL suggest that ZAS3 may influ-
ence the genetic programming of sensory neurons and
astrocytes, leading to neuropathic pain.
Immuno-studies show ZAS3 protein isoforms of 200 kDa,
190 kDa and 70 kDa are produced in DRG of naïve rats.
The 200 kDa species, which reacted with both ZAS3 antis-
era, is located in the nucleus, whereas the 70 kDa species,
which reacted with AbN but not AbC, is located in the
cytoplasm (Figure 6). Likely, these ZAS3 protein isoforms
may perform distinct functions in DRG. The size of the
larger ZAS3 proteins and their immunogenicitysuggest it
is most likely a ZAS3 protein isoform that is generated by
an alternatively spliced ZAS3 transcript in which exon 13
was spliced out (Figure 7B, bottom panel). Alternative
splicing of exon 13 is demonstrated by the smaller PCR
product in RT-PCR using the 3' primer set (Figure 8A).
ZAS3 transcripts that lack exon 13 will produce a trun-
cated protein of 1700 amino acid residues that contains
the ZASN domain, zinc finger 3 and the middle conserved
region, but lacks the ZASC domain (Figure 7B, bottom
panel).
The 70 kDa cytoplasmic ZAS3 protein isoform reacted
with AbN but not with AbC. AbN was raised against a
fusion protein that contained the ZASN domain (Figure
1A). In the mouse ZAS3 gene, the ZASN domain is
encoded by intron 10 when it is retained in the mature
transcript [30]. Exon 10-intron10-exon 11 together are
more than 5.5 kb in size and encodes the first 1654 amino
acids. Therefore, the 70 kDa ZAS3 protein isoform should
be generated by an undefined alternative splicing event or
by protein processing. Previously, it has been shown that
this protein region associates with TRAF2 to inhibit TNFα/
NF-κB signaling and with c-jun to induce AP1 transcrip-
tion [21,39] Therefore, the cytoplasmic 70 kDa protein is
an appropriate ZAS3 candidate isoform for the regulation
of signal transduction.
As in most cell types, NF-κB is present mainly in the cyto-
plasm of unstimulated DRG neurons [40]. Immunoblot
analyses show that in SpNL, the overall amount and
nuclear localization of p65 in ipsilateral DRG was more
than those in contralateral DRG (Figure 8). A similar
increase and activation (that is nuclear localization) of
p65-IR was observed in ipsilateral DRG neurons after tight
ligation of the sciatic nerve [40]. Likely, upregulation and
activation of NF-κB is a general response to peripheral
nerve injury. In SpNL, downregulation of ZAS3 may lead
to the translocation of NF-κB from the cytoplasm into the
nucleus. NF-κB activation, and a release of κB-DNA bind-
ing competition and transcription repression by ZAS3
together in turn activates NF-κB-dependent gene expres-
sion, pro-inflammatory cytokine expression, sensitization
of neurons, and neuropathic pain. Our observation sug-
gests that after nerve injury, downregulation of ZAS3 may
activate a cascade of NF-κB signal transduction and tran-
scriptional events which leads to neuronal regeneration
and neuropathic pain. Hence, via its regulatory role on
NF-κB, ZAS3 might be a new target for the prevention,
management, and resolution of persistent pain states fol-
lowing nerve injury.
Conclusion
This report is the first to characterize the protein expres-
sion and function of a large zinc finger protein ZAS3 in the
nervous system, and use an animal model to demonstrate
a functional relationship between ZAS3 and NF-κB. Previ-
ous RNA studies have shown specific expression of ZAS3
in lymphoid and nervous tissues. Here immunohisto-
chemical studies further localize ZAS3 expression to spe-
cific regions of the brain, including trigeminal ganglion
and hippocampus formation, spinal cord, and dorsal root
ganglia. Additionally, the cell-types that expressed ZAS3
in the nervous tissues are refined to neurons and astro-
cytes. The cellular distribution of the immunoreactivity
and the results of Western blot analysis using cytoplasmic
extracts and nuclear extracts suggest that ZAS3 protein iso-
forms with differential cellular localization are produced
in a tissue-specific manner. The notion that ZAS3 may
safe-guard cells from aberrant NF-κB activation stems
Immunoblot analysis of ZAS3 in brain and DRG Figure 6
Immunoblot analysis of ZAS3 in brain and DRG. Proteins (T), 
cytoplasmic extracts (C), and nuclear extracts (N) resolved 
by SDS-PAGE was sequentially incubated with antibodies 
AbC (A), p65 (B), and AbN (C). T, total protein lysate; C, 
cytoplasmic extracts; and N, nuclear extracts.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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Downregulation of ZAS3 in SpNL Figure 8
Downregulation of ZAS3 in SpNL. (A) Upper panels, RT-PCR transcript analyses of ZAS1, ZAS2, ZAS3, NGF and actin of DRG 
seven days after SpNL nerves (top panel). The experiments were carried out as described in the text (n = 4 per group) and a 
representative result is shown. (Bottom panel) Bar charts showing relative levels of each PCR products adjusted with actin in 
the same cDNA sample. Significance (*) is p < 0.05. (B) Immunoblot analyses of total protein lysates in ipsilateral (I) DRG and 
contralateral (Con) DRG prepare from rats seven days after surgery using AbC (a), AbN (b), and p65 antibodies (c). Asterisk 
indicates the 200 kDa species observed only in contralateral DRG but not in ipsilateral DRG. (C) Immunoblot analysis of cyto-
plasmic and nuclear extracts with p65 and histone H1 antibodies.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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from the fact that ZAS3 and NF-κB share similar DNA tar-
gets, the κB motif or similar sequences and that NF-κB is
activated in ZAS3-knockout cells. In vitro studies further
show that ZAS3 may inhibit the activation of NF-κB by
associating with TRAF2. TRAF2 is an adaptor molecule
essential for the assembly of a kinase complex that ulti-
mately activates NF-κB. In this report, we further show the
effect of L5 and L6 spinal nerve ligation (SpNL), a neuro-
pathic pain model, on the expression of ZAS3 and NF-κB.
In SpNL, ZAS3 transcripts and proteins are downregu-
lated, whereas NF-κB is upregulated and activated. Thus,
the reciprocal expression of ZAS3 and NF-κB in the neuro-
pathic pain model described here provides a relevant
physiological model to demonstrate the intimate func-
tional relationship of these κB binding proteins, and sug-
gest that downregulation of ZAS3 followed by
upregulation of NF-κB to be two initial steps that triggers
a cascade of gene activation and signaling events that lead




Male Sprague-Dawley rats (Harlan, Indianapolis, IN)
weighing 200 g to 250 g were used for all experiments in
compliance with animal protocols approved by the Ohio
State University Institutional Laboratory Animal Care and
Use Committee. Each experiment or analysis was repeated
with three to five animals, and consistent results were
obtained.
Spinal nerve ligation and testing for mechanical allodynia, 
and DRG isolation
For the spinal nerve ligation (SpNL) peripheral neuropa-
thy model, rats were anesthetized with isoflurane and the
left lumbar spinal nerves L5 and L6 were ligated tightly
with 6-0 silk as described by Kim and Chung [29]. Sham
surgery rats (SHAM) were treated similarly except that the
spinal process was not removed to avoid damage to the
underlying nerves, and the spinal nerves remained undis-
turbed. Allodynic responses to mechanical stimuli of both
feet were determined using calibrated von Frey sensory
monofilaments (Stoetling, Wood Dale, IL) and the "up
and down" method [41] yielding a 50% threshold in g
force. Rats were tested for two days before surgery, and at
day 6 after surgery by an individual blinded as to the
nature of the surgery. Post-surgery values are given in the
text. Rats not responding to the stiffest fiber, 5.38, were
given a score of 23.99 g. The Mann-Whitney non-paramet-
ric test was used to compare pre- and post-surgery ipsilat-
eral SpNL allodynia. Behavioral values are expressed as
mean ± S.E.M. Seven days post-surgery, rats were anesthe-
tized with chloral hydrate, and the ipsilateral and contral-
ateral L6 DRG were surgically removed, immediately
frozen on dry ice, and stored at -80°C until analyzed.
Immunohistochemistry
Naïve rats were deeply anesthetized with chloral hydrate
(500 mg/kg), perfused transcardially with 200 ml of nor-
mal saline, and then with 500 ml of ice-cold 4% parafor-
maldehyde in 0.1 M phosphate buffer (pH 7.2). Whole
brain, trigeminal ganglion, spinal cord, and L3 to L6 DRG
were surgically removed and fresh frozen. Immunostain-
ing of tissue sections (10–12 µM thick) was performed
using polyclonal rabbit ZAS3 antisera, AbN and AbC,
[17,42]., and goat glial fibrillary acidic protein (GFAP)
antibodies (Santa Cruz, sc-6170) as described [34]. Some
slides were also incubated with the fluorescent dye 4',6-
diamidino-2-phenylindole (DAPI) (Molecular probe, D-
1306; 0.5 µg/ml) to stain nuclei, or with cresyl violet
(0.5%; ICN Biomedicals Inc., Aurora, OH) to stain neu-
rons. Empirical experiments using a titration of each pri-
mary antibody from 100- to 1000-fold dilutions were
performed to establish the best signal to background
ratio. At least 6 slides from each tissue sample were exam-
ined, photographed using a Zeiss Axioscope fluorescent
microscope attached to a digital camera (Magnafire Olym-
pus), and consistent results were observed. Control exper-
iments in which primary antibodies were replaced with
normal rabbit serum or donkey serum yielded back-
ground signals. Controls for double label experiments
consisted of incubating the slides with each primary anti-
body followed by the inappropriate secondary antibody.
Immunoblot analyses
Brain, cut at Bregma -8.80 and the portion rostral to the
rostral edge of the cerebellum, including most of the mid-
brain, all of the forebrain and the cortex but excluding the
brain stem and cerebellum, and L5 and L6 DRG were
used. Total protein lysates were obtained by homogeniz-
ing fresh frozen tissues in extraction buffer (5 ml/g tissues;
8 M urea and 4% CHAPS) with a pellet pestle and clearing
by centrifugation. Cytoplasmic and nuclear extracts were
prepared as described [25]. The presence of equivalent
protein loading was shown by reversible protein staining
(GelCode E-Zinc Reversible stain kit, Catalog number
24582; Pierce, Rockford, IL) of gels before transferring
proteins onto nitrocellulose membranes. Immunoblot
analyses using the ZAS3 antisera, antibodies against NF-
κB p65 subunit, hsp90, or histone H1 (Santa Cruz Bio-
technology) were performed as described [25].
In Silico cloning of rat ZAS3 cDNA
The published mouse ZAS3 cDNA (8755 bp; GenBank
Accession Number L46815) was input for BLAST analysis
against the rat genomic DNA sequences (NW_047719) in
the NCBI databases. Exons, predicted from matching rat
gene sequences and referred to the mouse exon intron
boundaries (23), were joined to obtain a rat ZAS3 cDNA
sequence of 8759 bp.BMC Neuroscience 2006, 7:4 http://www.biomedcentral.com/1471-2202/7/4
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Reverse transcriptase-polymerase chain reaction
Total RNA was isolated from fresh frozen DRG using the
Purescript total RNA kit (Gentra Systems, Minneapolis,
MN). Semi-quantitative RT-PCR was performed with total
RNA using a one-step RT-PCR kit (catalog number 10928-
034; Invitrogen Carlsbad, CA). The sequences of each
gene-specific primer set used, GenBank accession num-
bers, and size of PCR products are shown in Table 1. Syn-
thesis of cDNA was performed at 50°C for 20 min. PCR
conditions were 94°C for 1 min; 56°C for 1 min; 72°C
for 45 sec (29 cycles); and a final extension step at 72°C
for 10 min. These conditions gave linear amplification of
all mRNA examined. PCR products were resolved by aga-
rose gel electrophoresis and visualized by ethidium bro-
mide staining. The relative amount of each PCR product
was determined from photographs of DNA gels using Lab-
Works™ Image Acquisition and analyzing Software (UVP
Inc. Upland CA 91786) and normalized to β-actin. The
values between ipsilateral and contralateral sides were
analyzed by Student's t-test, and when p < 0.05, the data
were considered statistically significant.
List of abbreviations used
ZAS zinc finger, acidic and ser/thr-rich regions
κB kappa B
NF-κB nuclear factor kappa B
TNFα tumor necrosis factor alphpa
TRAF2 tumor necrosis factor receptor-associated factor 2
IL interleukin
DRG dorsal root ganglia
HIVEP3 human immunodeficiency virus type 1 enhancer-
binding protein 3
SpNL spinal nerve ligation
RT-PCR reverse transcription-polymerase chain reaction
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